Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential-Reference-Cited by-同舟云学术

Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential

Published:2024-08-21 Issue: Volume: Page:
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Afsar S.,Syed Rahamat Unissa,Khojali Weam M. A.,Masood Najat,Osman Mhdia Elhadi,Jyothi J. Siva,Hadi Mohd. Abdul,Khalifa Amna Abakar Suleiman,Aboshouk Nayla Ahmed Mohammed,Alsaikhan Hessa Ahmed,Alafnan Aljuri Saleh,Alrashidi Bushra Abdullah

Funder

University of Hail

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00210-024-03366-3.pdf

Reference219 articles.

1. Acunzo M, Romano G, Wernicke D, Croce CM (2015) MicroRNA and cancer–a brief overview. Adv Biol Regul 57:1–9

2. Adler NR, Wolfe R, Kelly JW, Haydon A, McArthur GA, McLean CA, Mar VJ (2017) Tumour mutation status and sites of metastasis in patients with cutaneous melanoma. Br J Cancer 117:1026–1035

3. Aftab MN, Dinger ME, Perera RJ (2014) The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys 563:60–70

4. Alharbi KS, Joshi N, Singh Y, Almalki WH, Kazmi I, Al-Abbasi FA, Alzarea SI, Afzal O, Altamimi ASA, Gupta G (2022) Molecular exploration of hidden pleiotropic activities of azoles on dermatophytes in human tinea corporis infection. J De Mycologie Medicale 32:101311

5. Alzhrani R, Alsaab HO, Petrovici A, Bhise K, Vanamala K, Sau S, Krinock MJ, Iyer AK (2020) Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems. Drug Discovery Today 25:718–730